Decreased incidence of retinopathy of prematurity, 1995-1997

Journal of AAPOS

Volumn 5, Issue 2, 2001, Pages 118-122

  Blair, B Matthew ^a   O'Halloran, Harry S ^a   Pauly, Thomas H ^a   Stevens, Julia L ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ARTICLE; COMPARATIVE STUDY; FACTUAL DATABASE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN THERAPY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES; VERY LOW BIRTH WEIGHT;

DATABASES, FACTUAL; FOLLOW-UP STUDIES; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; KENTUCKY; OXYGEN INHALATION THERAPY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES;

EID: 0035316137     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpa.2001.113843     Document Type: Article

References (17)

1. Goggin M, O'Keefe M. Childhood blindness in the Republic of Ireland-a national survey. Br J Ophthalmol 1991;75:425-9.
2. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100:230-7.
3. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-40.
4. Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of prematurity. J AAPOS 1999;3:46-52.
5. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999;104:e26.
6. O'Halloran HS, Stevens JL, Rychwalski PJ, Blair BM, Pauly TH. Low incidence of retinopathy of prematurity in a tertiary care neonatal intensive care neonatal intensive care unit. Paper presented at: the 25th Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus; April 15-18, 1999; Toronto, Ontario, Canada.
7. Horbar JD, editor. Vermont-oxford network 1997 database summary. Burlington: Vermont-Oxford Network, Inc; 1998.
8. Kennedy J, Todd DA, Watts J, John E. Retinopathy of prematurity in infants less than 29 weeks' gestation: 3 1/2 years pre-and postsurfactant. J Pediatr Ophthalmol Strabismus 1997;34:289-92.
9. Fledelius HC. Retinopathy of prematurity in a Danish country: trends over the 12-year period 1982-93. Acta Ophthalmol Scand 1996;74:285-7.
10. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hedricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998;116:601-5.
11. Horbar JD. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol 1995;173:275-9.
12. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996;103:2099-104.
13. Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol 1995;22:641-55.
14. Brooks SE, Marcus DM, Gillis D, Pirie E, Johnson MG, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study. Pediatrics 1999;104:514-8.
15. Gaynon MW, Stevenson DK, Sunshine P, Fleisher BE, Landers MB. Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol 1997;17:434-8.
16. Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 1995;36:2063-70.
17. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I. Primary outcomes. Pediatrics 2000; 105:295-310.